Regulus Therapeutics Stock Price (NASDAQ:RGLS)

Add to My Stocks
$0.19 $0 (0%) RGLS stock closing price Sep 20, 2018 (Closing)
Prev Close* : $0.19
Market Cap:
$19.53M
Day Low: $0.19
52 Week Low: $0.17
Open: $0.2
Volume: -
Day High: $0.2
52 Week High: $1.52
Dividend:
0.00

Latest Stock Market News

Latest Articles

Regulus Therapeutics News - From Partners

RGLS Stockcharts

View RGLS PE ratio, PS ratio stocks charts and compare with peers.
RGLS Chart
Note: Compare Regulus Therapeutics stock price history with the index and industry peers.

Regulus Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
247.76
PB ratio (
price to book ratio
)
0.72

Regulus Therapeutics Returns

ROE
(return on equity)
-219%

Regulus Therapeutics Financial Ratios

Asset Turnover
0
Receivables Turnover
0.21
Debt to Equity
1.91
Dividend Yield
0%

RGLS Industry Peers

Company Price Change (%)
Midatech Pharma (MTP)0.740.01 (1.37%)
Shineco Inc (TYHT)1.070.05 (4.9%)
Achillion Pharma (ACHN)3.540.28 (8.59%)
Kadmon Holdings (KDMN)3.350.01 (0.3%)
Astrazeneca (AZN)37.720.42 (1.13%)
Sanofi (SNY)44.150.25 (0.57%)
Enzon Pharma (ENZN)0.260.01 (4%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Galectin Therapeutics (GALT)6.930.88 (14.55%)
Lannett Co (LCI)5.50.65 (13.4%)
TherapeuticsMD (TXMD)6.750.53 (8.52%)
Akebia Therapeutics (AKBA)8.330.59 (7.62%)
ArQule (ARQL)5.150.3 (6.19%)
Enanta Pharma (ENTA)97.685.59 (6.07%)
CTI BioPharma (CTIC)2.010.1 (5.24%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Rigel Pharma (RIGL)3.320.27 (7.52%)
MOLECULAR TEMPL (MTEM)5.790.46 (7.36%)
Achaogen (AKAO)4.310.25 (5.48%)
Flexion Therapeutics (FLXN)18.870.75 (3.82%)
CORREVIO PHARMA (CORV)4.290.1 (2.28%)
Heron Therapeutics (HRTX)33.10.6 (1.78%)
Portola Pharma (PTLA)28.170.46 (1.61%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

Regulus Therapeutics Inc Stock News - Partner Headlines

Regulus Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues-1.19M20.75M7.66M19.56M
Net Income-71.9M-81.83M-55.74M-56.68M-18.66M
Total Operating Expense70.2M82.69M75.51M52.57M37.36M
View Regulus Therapeutics income statement
balance sheet20172016201520142013
Total Assets77.8M100.66M141.08M171.48M123.06M
Total Liabilities42.59M44.58M17M39.46M29.6M
Shareholders Equity35.21M56.07M124.07M132.01M93.45M
View Regulus Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities2.01M8.1M-14.45M-5.09M-17.02M
Net Cash from (used by) Operating Activities-58.77M-56.88M-49.85M-39.51M-28.33M
Increase (Decrease) in Prop Plant And Equipment-0.3M-0.91M-1.36M-1.14M-0.8M
View Regulus Therapeutics cash flow statement

Regulus Therapeutics Stock Message Board

As of last trading day, Regulus Therapeutics stock price was $0.19. Looking at Regulus Therapeutics market capitalization, which currently stands at $19.53M, we can say that RGLS stock is a Nano Cap stock. A value investor must look at the fundamentals of a stock, and perform Regulus Therapeutics valuation, even though in the short-term, sentiment and current breaking news might affect Regulus Therapeutics stock price.

The terms stocks and shares mean the same thing. For Ex: Regulus Therapeutics stock price and Regulus Therapeutics share price mean the same thing. 331,921 shares were traded with a closing stock price of $0.19 as of Sep 20, 2018, as can be seen from Regulus Therapeutics stock quote. One can view Regulus Therapeutics stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Regulus Therapeutics stock dividend was 0.00 during the last quarter. To check the historical stock price movement, all time high, and all time low of RGLS, view Regulus Therapeutics stock price history.